These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 3756937

  • 1. Aminoglutethimide without hydrocortisone in the treatment of postmenopausal patients with advanced breast cancer.
    Höffken K, Kempf H, Miller AA, Miller B, Schmidt CG, Faber P, Kley HK.
    Cancer Treat Rep; 1986 Oct; 70(10):1153-7. PubMed ID: 3756937
    [Abstract] [Full Text] [Related]

  • 2. Aminoglutethimide in the treatment of advanced postmenopausal breast cancer.
    Harris AL, Powles TJ, Smith IE.
    Cancer Res; 1982 Aug; 42(8 Suppl):3405s-3408s. PubMed ID: 7083207
    [Abstract] [Full Text] [Related]

  • 3. Aminoglutethimide in the treatment of metastatic breast cancer.
    Troner MB.
    Cancer Res; 1982 Aug; 42(8 Suppl):3402s-3404s. PubMed ID: 7083206
    [Abstract] [Full Text] [Related]

  • 4. Aminoglutethimide as second line therapy in advanced breast cancer.
    Elomaa I, Blomqvist C, Rissanen P.
    Breast Cancer Res Treat; 1986 Aug; 7 Suppl():S51-4. PubMed ID: 3017481
    [Abstract] [Full Text] [Related]

  • 5. Aminoglutethimide as second line endocrine therapy in advanced breast cancer.
    Brufman G, Biran S.
    Anticancer Res; 1986 Aug; 6(5):1065-8. PubMed ID: 3800315
    [Abstract] [Full Text] [Related]

  • 6. Randomized trial of aminoglutethimide versus tamoxifen in metastatic breast cancer.
    Lipton A, Harvey HA, Santen RJ, Boucher A, White D, Bernath A, Dixon R, Richards G, Shafik A.
    Cancer Res; 1982 Aug; 42(8 Suppl):3434s-3436s. PubMed ID: 7044526
    [Abstract] [Full Text] [Related]

  • 7. Use of aminoglutethimide as second-line endocrine therapy in metastatic breast cancer.
    Kaye SB, Woods RL, Fox RM, Coates AS, Tattersall MH.
    Cancer Res; 1982 Aug; 42(8 Suppl):3445s-3447s. PubMed ID: 6177404
    [Abstract] [Full Text] [Related]

  • 8. Tamoxifen versus aminoglutethimide versus combined tamoxifen and aminoglutethimide in the treatment of advanced breast carcinoma.
    Smith IE, Harris AL, Morgan M, Gazet JC, McKinna JA.
    Cancer Res; 1982 Aug; 42(8 Suppl):3430s-3433s. PubMed ID: 7044525
    [Abstract] [Full Text] [Related]

  • 9. Treatment of metastatic breast cancer with aminoglutethimide after progression on chemotherapy and/or hormonal therapy with tamoxifen.
    Brufman G, Biran S.
    Eur J Surg Oncol; 1985 Mar; 11(1):27-31. PubMed ID: 2985452
    [Abstract] [Full Text] [Related]

  • 10. [Aminoglutethimide therapy in advanced breast cancer].
    Kühböck J, Ludwig H, Pötzi P, Zielinski C.
    Wien Med Wochenschr; 1985 Dec 31; 135(23-24):608-11. PubMed ID: 4096007
    [Abstract] [Full Text] [Related]

  • 11. Phase II study of aminoglutethimide and medroxyprogesterone acetate in the treatment of patients with advanced breast cancer.
    Nagel GA, Wander HE, Blossey HC.
    Cancer Res; 1982 Aug 31; 42(8 Suppl):3442s-3444s. PubMed ID: 6123383
    [Abstract] [Full Text] [Related]

  • 12. [The use of aminoglutethimide (orimeten) in disseminated breast cancer].
    Nadezhdina TM, Vyshinskaia GV, Lichinitser MR, Bassalyk LS, Garin AM.
    Vopr Onkol; 1987 Aug 31; 33(5):79-82. PubMed ID: 3590672
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Phase II study of vorozole (R83842), a new aromatase inhibitor, in postmenopausal women with advanced breast cancer in progression on tamoxifen.
    Goss PE, Clark RM, Ambus U, Weizel HA, Wadden NA, Crump M, Walde D, Tye LM, De Coster R, Bruynseels J.
    Clin Cancer Res; 1995 Mar 31; 1(3):287-94. PubMed ID: 9815984
    [Abstract] [Full Text] [Related]

  • 17. Aminoglutethimide after tamoxifen therapy in advanced breast cancer: M. D. Anderson Hospital experience.
    Buzdar AU, Powell KC, Blumenschein GR.
    Cancer Res; 1982 Aug 31; 42(8 Suppl):3448s-3450s. PubMed ID: 7083209
    [Abstract] [Full Text] [Related]

  • 18. Complete estrogen blockade with buserelin and aminoglutethimide for advanced breast cancer: a phase I-II study with long-term hormonal correlations.
    Ferrari V, Zaniboni A, Simoncini E, Marpicati E, Montini E, Moretti R, Marini G.
    Chemioterapia; 1988 Dec 31; 7(6):414-9. PubMed ID: 3146444
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Influence of aminoglutethimide on plasma levels of medroxyprogesterone acetate: its correlation with serum cortisol.
    Van Deijk WA, Blijham GH, Mellink WA, Meulenberg PM.
    Cancer Treat Rep; 1985 Jan 31; 69(1):85-90. PubMed ID: 3155651
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.